Jill E. Sackman, PhD is a senior consultant at Numerof & Associates, Inc.
The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
The pharmaceutical industry grows despite conflict in the Middle East.
The bio-pharmaceutical business outlook in South Korea remains positive
A unique demographic and payer mix make ASEAN an increasingly attractive region.
Eastern Europe is moving towards a goal of harmonized regulations.
An introduction to a new series on manufacturing within global markets.
The industry must be prepared for the impact of the sweeping changes expected from the new legislation.